{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:02:49Z","timestamp":1794405769896,"version":"4.9.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","award":["NNF19OC0054481"],"award-info":[{"award-number":["NNF19OC0054481"]}],"id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","award":["NNF19OC0054481"],"award-info":[{"award-number":["NNF19OC0054481"]}],"id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","award":["NNF19OC0054481"],"award-info":[{"award-number":["NNF19OC0054481"]}],"id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05040-2","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:36:36Z","timestamp":1777181796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Urine-derived stem cells in kidney disease: progress, challenges, and future directions"],"prefix":"10.1186","volume":"17","author":[{"given":"Jasmine C. L.","family":"Atay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Toftegaard","family":"Boysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke","family":"N\u00f8rregaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"issue":"4, Supplement","key":"5040_CR1","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4, Supplement):S117-314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","journal-title":"Kidney Int"},{"issue":"6","key":"5040_CR2","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00467-011-1992-9","volume":"27","author":"KS Hodgkins","year":"2012","unstructured":"Hodgkins KS, Schnaper HW. Tubulointerstitial injury and the progression of chronic kidney disease. Pediatr Nephrol. 2012;27(6):901\u20139. https:\/\/doi.org\/10.1007\/s00467-011-1992-9.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"5040_CR3","doi-asserted-by":"publisher","first-page":"c81","DOI":"10.1159\/000314656","volume":"116","author":"B Rodr\u00edguez-Iturbe","year":"2010","unstructured":"Rodr\u00edguez-Iturbe B, Garc\u00eda Garc\u00eda G. The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron Clin Pract. 2010;116(2):c81-88. https:\/\/doi.org\/10.1159\/000314656.","journal-title":"Nephron Clin Pract"},{"issue":"11","key":"5040_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrneph.2010.120","volume":"6","author":"P Boor","year":"2010","unstructured":"Boor P, Ostendorf T, Floege J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol. 2010;6(11):643\u201356. https:\/\/doi.org\/10.1038\/nrneph.2010.120.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"5040_CR5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ki.2008.351","volume":"74","author":"DO Schlondorff","year":"2008","unstructured":"Schlondorff DO. Overview of factors contributing to the pathophysiology of progressive renal disease. Kidney Int. 2008;74(7):860\u20136. https:\/\/doi.org\/10.1038\/ki.2008.351.","journal-title":"Kidney Int"},{"key":"5040_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1101068","volume":"14","author":"S Alshahrani","year":"2023","unstructured":"Alshahrani S. Renin\u2013angiotensin\u2013aldosterone pathway modulators in Chronic Kidney Disease: a comparative review. Front Pharmacol. 2023;14:1101068. https:\/\/doi.org\/10.3389\/fphar.2023.1101068.","journal-title":"Front Pharmacol"},{"issue":"1","key":"5040_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12325-021-01994-2","volume":"39","author":"CW Mende","year":"2022","unstructured":"Mende CW. Chronic Kidney Disease and SGLT2 inhibitors: a review of the evolving treatment landscape. Adv Ther. 2022;39(1):148\u201364. https:\/\/doi.org\/10.1007\/s12325-021-01994-2.","journal-title":"Adv Ther"},{"key":"5040_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/09636897231164251","volume":"32","author":"F Chen","year":"2023","unstructured":"Chen F, Chen N, Xia C, Wang H, Shao L, Zhou C, et al. Mesenchymal Stem Cell Therapy in kidney diseases: potential and challenges. Cell Transplant. 2023;32:09636897231164251. https:\/\/doi.org\/10.1177\/09636897231164251.","journal-title":"Cell Transplant"},{"issue":"6","key":"5040_CR9","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s10157-021-02030-x","volume":"25","author":"K Osafune","year":"2021","unstructured":"Osafune K. iPSC technology-based regenerative medicine for kidney diseases. Clin Exp Nephrol. 2021;25(6):574\u201384. https:\/\/doi.org\/10.1007\/s10157-021-02030-x.","journal-title":"Clin Exp Nephrol"},{"issue":"11","key":"5040_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112790","volume":"20","author":"C Rota","year":"2019","unstructured":"Rota C, Morigi M, Imberti B. Stem cell therapies in kidney diseases: progress and challenges. Int J Mol Sci. 2019;20(11):2790. https:\/\/doi.org\/10.3390\/ijms20112790.","journal-title":"Int J Mol Sci"},{"key":"5040_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.semcdb.2019.10.014","volume":"101","author":"JS Rockel","year":"2020","unstructured":"Rockel JS, Rabani R, Viswanathan S. Anti-fibrotic mechanisms of exogenously-expanded mesenchymal stromal cells for fibrotic diseases. Semin Cell Dev Biol. 2020;101:87\u2013103. https:\/\/doi.org\/10.1016\/j.semcdb.2019.10.014.","journal-title":"Semin Cell Dev Biol"},{"issue":"8","key":"5040_CR12","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nm.3267","volume":"19","author":"AS Lee","year":"2013","unstructured":"Lee AS, Tang C, Rao MS, Weissman IL, Wu JC. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med. 2013;19(8):998\u20131004. https:\/\/doi.org\/10.1038\/nm.3267.","journal-title":"Nat Med"},{"issue":"8","key":"5040_CR13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.tibtech.2024.01.009","volume":"42","author":"P Yu","year":"2024","unstructured":"Yu P, Bosholm CC, Zhu H, Duan Z, Atala A, Zhang Y. Beyond waste: understanding urine\u2019s potential in precision medicine. Trends Biotechnol. 2024;42(8):953\u201369. https:\/\/doi.org\/10.1016\/j.tibtech.2024.01.009.","journal-title":"Trends Biotechnol"},{"issue":"5","key":"5040_CR14","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/j.juro.2008.07.023","volume":"180","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, McNeill E, Tian H, Soker S, Andersson KE, Yoo JJ, et al. Urine derived cells are a potential source for urological tissue reconstruction. J Urol. 2008;180(5):2226\u201333. https:\/\/doi.org\/10.1016\/j.juro.2008.07.023.","journal-title":"J Urol"},{"issue":"9","key":"5040_CR15","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1002\/stem.1424","volume":"31","author":"S Bharadwaj","year":"2013","unstructured":"Bharadwaj S, Liu G, Shi Y, Wu R, Yang B, He T, et al. Multipotential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology. Stem Cells. 2013;31(9):1840\u201356. https:\/\/doi.org\/10.1002\/stem.1424.","journal-title":"Stem Cells"},{"issue":"12","key":"5040_CR16","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2015.30.12.1764","volume":"30","author":"HS Kang","year":"2015","unstructured":"Kang HS, Choi SH, Kim BS, Choi JY, Park GB, Kwon TG, et al. Advanced properties of urine derived stem cells compared to adipose tissue derived stem cells in terms of cell proliferation, immune modulation and multi differentiation. J Korean Med Sci. 2015;30(12):1764. https:\/\/doi.org\/10.3346\/jkms.2015.30.12.1764.","journal-title":"J Korean Med Sci"},{"key":"5040_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/362562","volume":"2015","author":"F Oliveira Arcolino","year":"2015","unstructured":"Oliveira Arcolino F, Tort Piella A, Papadimitriou E, Bussolati B, Antonie DJ, Murray P, et al. Human urine as a noninvasive source of kidney cells. Stem Cells Int. 2015;2015:362562. https:\/\/doi.org\/10.1155\/2015\/362562.","journal-title":"Stem Cells Int"},{"issue":"15\u201316","key":"5040_CR18","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1089\/ten.TEA.2010.0637","volume":"17","author":"S Bharadwaj","year":"2011","unstructured":"Bharadwaj S, Liu G, Shi Y, Markert C, Andersson KE, Atala A, et al. Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. Tissue Eng Part A. 2011;17(15\u201316):2123\u201332. https:\/\/doi.org\/10.1089\/ten.TEA.2010.0637.","journal-title":"Tissue Eng Part A"},{"key":"5040_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1186\/s13104-015-1686-7","volume":"8","author":"M Schosserer","year":"2015","unstructured":"Schosserer M, Reynoso R, Wally V, Jug B, Kantner V, Weilner S, et al. Urine is a novel source of autologous mesenchymal stem cells for patients with epidermolysis bullosa. BMC Res Notes. 2015;8:767. https:\/\/doi.org\/10.1186\/s13104-015-1686-7. PubMed PMID: 26654529; PubMed Central PMCID: PMC4676112.","journal-title":"BMC Res Notes"},{"issue":"9","key":"5040_CR20","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.21037\/tau-21-506","volume":"10","author":"R Wu","year":"2021","unstructured":"Wu R, Soland M, Liu G, Shi Y, Zhang C, Tang Y, et al. Functional characterization of the immunomodulatory properties of human urine-derived stem cells. Transl Androl Urol. 2021;10(9):3566\u201378. https:\/\/doi.org\/10.21037\/tau-21-506.","journal-title":"Transl Androl Urol"},{"issue":"5","key":"5040_CR21","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/ecco-jcc\/jjz200","volume":"14","author":"C Zhou","year":"2020","unstructured":"Zhou C, Wu X, Liu H, Liu X, Liu G, Zheng X, et al. Immunomodulatory effect of urine-derived stem cells on inflammatory bowel diseases via downregulating Th1\/Th17 immune responses in a PGE2-dependent manner. J Crohns Colitis. 2020;14(5):654\u201368. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz200.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"5040_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tmrv.2015.11.004","volume":"30","author":"MJ Fontaine","year":"2016","unstructured":"Fontaine MJ, Shih H, Sch\u00e4fer R, Pittenger MF. Unraveling the mesenchymal stromal cells\u2019 paracrine immunomodulatory effects. Transfus Med Rev. 2016;30(1):37\u201343. https:\/\/doi.org\/10.1016\/j.tmrv.2015.11.004.","journal-title":"Transfus Med Rev"},{"issue":"2","key":"5040_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/ten.teb.2011.0488","volume":"18","author":"J Doorn","year":"2012","unstructured":"Doorn J, Moll G, Le Blanc K, van Blitterswijk C, de Boer J. Therapeutic applications of mesenchymal stromal cells: Paracrine effects and potential improvements. Tissue Eng Part B Rev. 2012;18(2):101\u201315. https:\/\/doi.org\/10.1089\/ten.teb.2011.0488.","journal-title":"Tissue Eng Part B Rev"},{"key":"5040_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo M, Raposo G, Th\u00e9ry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255\u201389. https:\/\/doi.org\/10.1146\/annurev-cellbio-101512-122326.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"23","key":"5040_CR25","doi-asserted-by":"publisher","first-page":"10798","DOI":"10.1111\/jcmm.14558","volume":"25","author":"Y Duan","year":"2019","unstructured":"Duan Y, Chen B, Chen F, Yang S, Zhu C, Ma Y, et al. Exosomal microRNA-16\u20105p from human urine\u2010derived stem cells ameliorates diabetic nephropathy through protection of podocyte. J Cell Mol Med. 2019;25(23):10798\u2013813. https:\/\/doi.org\/10.1111\/jcmm.14558.","journal-title":"J Cell Mol Med"},{"issue":"21","key":"5040_CR26","doi-asserted-by":"publisher","first-page":"9561","DOI":"10.7150\/thno.42153","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Liao J, Su X, Li W, Bi Z, Wang J, et al. Human urine-derived stem cells protect against renal ischemia\/reperfusion injury in a rat model via exosomal miR-146a-5p which targets IRAK1. Theranostics. 2020;10(21):9561\u201378. https:\/\/doi.org\/10.7150\/thno.42153.","journal-title":"Theranostics"},{"key":"5040_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.610587","volume":"8","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang J, Yang B, Qiao R, Li A, Guo H, et al. Transfer of MicroRNA-216a-5p from exosomes secreted by human urine-derived stem cells reduces renal ischemia\/reperfusion injury. Front Cell Dev Biol. 2020;8:610587. https:\/\/doi.org\/10.3389\/fcell.2020.610587.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"5040_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13287-022-02986-x","volume":"13","author":"Z Sun","year":"2022","unstructured":"Sun Z, Wu J, Bi Q, Wang W. Exosomal lncRNA TUG1 derived from human urine-derived stem cells attenuates renal ischemia\/reperfusion injury by interacting with SRSF1 to regulate ASCL4-mediated ferroptosis. Stem Cell Res Ther. 2022;13(1):297. https:\/\/doi.org\/10.1186\/s13287-022-02986-x.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5040_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-016-0287-2","volume":"7","author":"Z Jiang","year":"2016","unstructured":"Jiang Z, Liu Y, Niu X, Yin J, Hu B, Guo S, et al. Exosomes secreted by human urine-derived stem cells could prevent kidney complications from Type I Diabetes in rats. Stem Cell Res Ther. 2016;7(1):24. https:\/\/doi.org\/10.1186\/s13287-016-0287-2.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5040_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053980","volume":"8","author":"R Lang","year":"2013","unstructured":"Lang R, Liu G, Shi Y, Bharadwaj S, Leng X, Zhou X, et al. Self-renewal and differentiation capacity of urine-derived stem cells after urine preservation for 24 hours. PLoS One. 2013;8(1):e53980. https:\/\/doi.org\/10.1371\/journal.pone.0053980.","journal-title":"PLoS One"},{"key":"5040_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4686259","author":"L Chen","year":"2018","unstructured":"Chen L, Li L, Xing F, Peng J, Peng K, Wang Y, et al. Human urine-derived stem cells: potential for cell-based therapy of cartilage defects. Stem Cells Int. 2018. https:\/\/doi.org\/10.1155\/2018\/4686259.","journal-title":"Stem Cells Int"},{"issue":"5","key":"5040_CR32","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s11427-018-9543-1","volume":"63","author":"AJ Chen","year":"2020","unstructured":"Chen AJ, Pi JK, Hu JG, Huang YZ, Gao HW, Li SF, et al. Identification and characterization of two morphologically distinct stem cell subpopulations from human urine samples. Sci China Life Sci. 2020;63(5):712\u201323. https:\/\/doi.org\/10.1007\/s11427-018-9543-1.","journal-title":"Sci China Life Sci"},{"key":"5040_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212503","author":"M Culenova","year":"2021","unstructured":"Culenova M, Nicodemou A, Novakova ZV, Debreova M, Smolinsk\u00e1 V, Bernatova S, et al. Isolation, culture and comprehensive characterization of biological properties of human urine-derived stem cells. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222212503.","journal-title":"Int J Mol Sci"},{"key":"5040_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03903-0","author":"AT Boysen","year":"2024","unstructured":"Boysen AT, Whitehead B, Revenfeld ALS, Gupta D, Petersen T, Nejsum P. Urine-derived stem cells serve as a robust platform for generating native or engineered extracellular vesicles. Stem Cell Res Ther. 2024. https:\/\/doi.org\/10.1186\/s13287-024-03903-0.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"5040_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315\u20137. https:\/\/doi.org\/10.1080\/14653240600855905.","journal-title":"Cytotherapy"},{"key":"5040_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2011.12.034","author":"SY Chun","year":"2012","unstructured":"Chun SY, Kim HT, Lee JS, Kim MJ, Kim BS, Kim BW, et al. Characterization of urine-derived cells from upper urinary tract in patients with bladder cancer. Urology. 2012. https:\/\/doi.org\/10.1016\/j.urology.2011.12.034.","journal-title":"Urology"},{"issue":"1","key":"5040_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-018-0932-z","volume":"9","author":"NPA Manaph","year":"2018","unstructured":"Manaph NPA, Al-Hawwas M, Bobrovskaya L, Coates PT, Zhou XF. Urine-derived cells for human cell therapy. Stem Cell Res Ther. 2018;9(1):189. https:\/\/doi.org\/10.1186\/s13287-018-0932-z.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"5040_CR38","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jcyt.2012.11.010","volume":"15","author":"MS Choudhery","year":"2013","unstructured":"Choudhery MS, Badowski M, Muise A, Harris DT. Comparison of human mesenchymal stem cells derived from adipose and cord tissue. Cytotherapy. 2013;15(3):330\u201343. https:\/\/doi.org\/10.1016\/j.jcyt.2012.11.010.","journal-title":"Cytotherapy"},{"issue":"14","key":"5040_CR39","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.7150\/thno.34050","volume":"9","author":"G Xiong","year":"2019","unstructured":"Xiong G, Tang W, Zhang D, He D, Wei G, Atala A, et al. Impaired regeneration potential in urinary stem cells diagnosed from the patients with diabetic nephropathy. Theranostics. 2019;9(14):4221\u201332. https:\/\/doi.org\/10.7150\/thno.34050.","journal-title":"Theranostics"},{"issue":"13\u201314","key":"5040_CR40","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1089\/ten.tea.2013.0584","volume":"20","author":"JJ Guan","year":"2014","unstructured":"Guan JJ, Niu X, Gong FX, Hu B, Guo SC, Lou YL, et al. Biological characteristics of human-urine-derived stem cells: potential for cell-based therapy in neurology. Tissue Eng Part A. 2014;20(13\u201314):1794\u2013806. https:\/\/doi.org\/10.1089\/ten.tea.2013.0584.","journal-title":"Tissue Eng Part A"},{"key":"5040_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.890574","author":"Y Shi","year":"2022","unstructured":"Shi Y, Liu G, Wu R, Mack DL, Sun XS, Maxwell J, et al. Differentiation capacity of human urine-derived stem cells to retain telomerase activity. Front Cell Dev Biol. 2022. https:\/\/doi.org\/10.3389\/fcell.2022.890574.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"5040_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/scrt458","volume":"5","author":"D Qin","year":"2014","unstructured":"Qin D, Long T, Deng J, Zhang Y. Urine-derived stem cells for potential use in bladder repair. Stem Cell Res Ther. 2014;5. https:\/\/doi.org\/10.1186\/scrt458.","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"5040_CR43","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.exphem.2008.03.004","volume":"36","author":"A Sorrentino","year":"2008","unstructured":"Sorrentino A, Ferracin M, Castelli G, Biffoni M, Tomaselli G, Baiocchi M, et al. Isolation and characterization of CD146\u2009+\u2009multipotent mesenchymal stromal cells. Exp Hematol. 2008;36(8):1035\u201346. https:\/\/doi.org\/10.1016\/j.exphem.2008.03.004.","journal-title":"Exp Hematol"},{"issue":"1","key":"5040_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-015-0266-z","volume":"7","author":"L Harkness","year":"2016","unstructured":"Harkness L, Zaher W, Ditzel N, Isa A, Kassem M. CD146\/MCAM defines functionality of human bone marrow stromal stem cell populations. Stem Cell Res Ther. 2016;7(1):1\u201313. https:\/\/doi.org\/10.1186\/s13287-015-0266-z.","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"5040_CR45","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1681\/ASN.2006010089","volume":"17","author":"C Sagrinati","year":"2006","unstructured":"Sagrinati C, Netti GS, Mazzinghi B, Lazzeri E, Liotta F, Frosali F, et al. Isolation and characterization of multipotent progenitor cells from the Bowman\u2019s Capsule of adult human kidneys. J Am Soc Nephrol. 2006;17(9):2443. https:\/\/doi.org\/10.1681\/ASN.2006010089.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"5040_CR46","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1681\/ASN.2007020210","volume":"18","author":"E Lazzeri","year":"2007","unstructured":"Lazzeri E, Crescioli C, Ronconi E, Mazzinghi B, Sagrinati C, Netti GS, et al. Regenerative potential of embryonic renal multipotent progenitors in acute renal failure. J Am Soc Nephrol. 2007;18(12):3128. https:\/\/doi.org\/10.1681\/ASN.2007020210.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"5040_CR47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.stem.2008.05.020","volume":"3","author":"A Kobayashi","year":"2008","unstructured":"Kobayashi A, Valerius MT, Mugford JW, Carroll TJ, Self M, Oliver G, et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell. 2008;3(2):169\u201381. https:\/\/doi.org\/10.1016\/j.stem.2008.05.020.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"5040_CR48","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.stem.2008.01.014","volume":"2","author":"BD Humphreys","year":"2008","unstructured":"Humphreys BD, Valerius MT, Kobayashi A, Mugford JW, Soeung S, Duffield JS, et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell. 2008;2(3):284\u201391. https:\/\/doi.org\/10.1016\/j.stem.2008.01.014.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"5040_CR49","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.stemcr.2016.03.008","volume":"6","author":"JA Oliver","year":"2016","unstructured":"Oliver JA, Sampogna RV, Jalal S, Zhang QY, Dahan A, Wang W, et al. A subpopulation of label-retaining cells of the kidney papilla regenerates injured kidney medullary tubules. Stem Cell Rep. 2016;6(5):757\u201371. https:\/\/doi.org\/10.1016\/j.stemcr.2016.03.008.","journal-title":"Stem Cell Rep"},{"issue":"6","key":"5040_CR50","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/ndt\/gfu281","volume":"30","author":"R Kramann","year":"2015","unstructured":"Kramann R, Kusaba T, Humphreys BD. Who regenerates the kidney tubule? Nephrol Dial Transplant. 2015;30(6):903\u201310. https:\/\/doi.org\/10.1093\/ndt\/gfu281.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"5040_CR51","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.celrep.2014.04.018","volume":"7","author":"Y Rinkevich","year":"2014","unstructured":"Rinkevich Y, Montoro DT, Contreras-Trujillo H, Harari-Steinberg O, Newman AM, Tsai JM, et al. In vivo clonal analysis reveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regeneration. Cell Rep. 2014;7(4):1270\u201383. https:\/\/doi.org\/10.1016\/j.celrep.2014.04.018.","journal-title":"Cell Rep"},{"issue":"7","key":"5040_CR52","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nrneph.2015.67","volume":"11","author":"P Romagnani","year":"2015","unstructured":"Romagnani P, Rinkevich Y, Dekel B. The use of lineage tracing to study kidney injury and regeneration. Nat Rev Nephrol. 2015;11(7):420\u201331. https:\/\/doi.org\/10.1038\/nrneph.2015.67.","journal-title":"Nat Rev Nephrol"},{"key":"5040_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mce.2016.03.001","volume":"427","author":"X Dong","year":"2016","unstructured":"Dong X, Zhang T, Liu Q, Zhu J, Zhao J, Li J, et al. Beneficial effects of urine-derived stem cells on fibrosis and apoptosis of myocardial, glomerular and bladder cells. Mol Cell Endocrinol. 2016;427:21\u201332. https:\/\/doi.org\/10.1016\/j.mce.2016.03.001.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"5040_CR54","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.3892\/mmr.2017.7240","volume":"16","author":"SF Tian","year":"2017","unstructured":"Tian SF, Jiang ZZ, Liu YM, Niu X, Hu B, Guo SC, et al. Human urine-derived stem cells contribute to the repair of ischemic acute kidney injury in rats. Mol Med Rep. 2017;16(4):5541\u20138. https:\/\/doi.org\/10.3892\/mmr.2017.7240.","journal-title":"Mol Med Rep"},{"key":"5040_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8035076","volume":"2019","author":"B Sun","year":"2019","unstructured":"Sun B, Luo X, Yang C, Liu P, Yang Y, Dong X, et al. Therapeutic effects of human urine-derived stem cells in a rat model of cisplatin-induced acute kidney injury in vivo and in vitro. Stem Cells Int. 2019;2019:1\u201313. https:\/\/doi.org\/10.1155\/2019\/8035076.","journal-title":"Stem Cells Int"},{"issue":"3","key":"5040_CR56","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.26355\/eurrev_202002_20189","volume":"24","author":"G Xiong","year":"2020","unstructured":"Xiong G, Tao L, Ma WJ, Gong MJ, Zhao L, Shen LJ, et al. Urine-derived stem cells for the therapy of diabetic nephropathy mouse model. Eur Rev Med Pharmacol Sci. 2020;24(3):1316\u201324. https:\/\/doi.org\/10.26355\/eurrev_202002_20189.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"5040_CR57","doi-asserted-by":"publisher","first-page":"435","DOI":"10.7150\/ijbs.37550","volume":"16","author":"C Zhang","year":"2020","unstructured":"Zhang C, George SK, Wu R, Thakker PU, Abolbashari M, Kim TH, et al. Reno-protection of urine-derived stem cells in a chronic kidney disease rat model induced by renal ischemia and nephrotoxicity. Int J Biol Sci. 2020;16(3):435\u201346. https:\/\/doi.org\/10.7150\/ijbs.37550.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"5040_CR58","doi-asserted-by":"publisher","first-page":"525","DOI":"10.4252\/wjsc.v16.i5.525","volume":"16","author":"F Li","year":"2024","unstructured":"Li F, Zhao B, Zhang L, Chen GQ, Zhu L, Feng XL, et al. Therapeutic potential of urine-derived stem cells in renal regeneration following acute kidney injury: a comparative analysis with mesenchymal stem cells. World J Stem Cells. 2024;16(5):525\u201337. https:\/\/doi.org\/10.4252\/wjsc.v16.i5.525.","journal-title":"World J Stem Cells"},{"issue":"7","key":"5040_CR59","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1016\/j.ymthe.2025.03.044","volume":"33","author":"J Bejoy","year":"2025","unstructured":"Bejoy J, Welch RC, Qian ES, Williams FM, Gibson-Corley KN, Wilson MH, et al. Urine-derived stem cells display homing, incorporation, and regeneration in human organoid and mouse models of acute kidney injury. Mol Ther. 2025;33(7):3307\u201320. https:\/\/doi.org\/10.1016\/j.ymthe.2025.03.044.","journal-title":"Mol Ther"},{"key":"5040_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092825","author":"B Ouyang","year":"2014","unstructured":"Ouyang B, Sun X, Han D, Chen S, Yao B, Gao Y, et al. Human urine-derived stem cells alone or genetically-modified with FGF2 improve type 2 diabetic erectile dysfunction in a rat model. PLoS One. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0092825.","journal-title":"PLoS One"},{"issue":"3","key":"5040_CR61","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/mt.2013.261","volume":"22","author":"AE Ryan","year":"2014","unstructured":"Ryan AE, Lohan P, O\u2019Flynn L, Treacy O, Chen X, Coleman C, et al. Chondrogenic differentiation increases antidonor immune response to allogeneic mesenchymal stem cell transplantation. Mol Ther. 2014;22(3):655\u201367. https:\/\/doi.org\/10.1038\/mt.2013.261.","journal-title":"Mol Ther"},{"issue":"Suppl 16","key":"5040_CR62","doi-asserted-by":"publisher","first-page":"S136","DOI":"10.1093\/joneph\/23.S16.S136","volume":"23","author":"MC Hu","year":"2010","unstructured":"Hu MC, Kuro-o M, Moe OW. Klotho and kidney disease. J Nephrol. 2010;23(Suppl 16):S136-44.","journal-title":"J Nephrol"},{"issue":"5","key":"5040_CR63","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s10157-012-0621-7","volume":"16","author":"Y Shimamura","year":"2012","unstructured":"Shimamura Y, Hamada K, Inoue K, Ogata K, Ishihara M, Kagawa T, et al. Serum levels of soluble secreted \u03b1-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis. Clin Exp Nephrol. 2012;16(5):722\u20139. https:\/\/doi.org\/10.1007\/s10157-012-0621-7.","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"5040_CR64","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1006\/bbrc.2000.4226","volume":"280","author":"N Koh","year":"2001","unstructured":"Koh N, Fujimori T, Nishiguchi S, Tamori A, Shiomi S, Nakatani T, et al. Severely reduced production of Klotho in human chronic renal failure kidney. Biochem Biophys Res Commun. 2001;280(4):1015\u201320. https:\/\/doi.org\/10.1006\/bbrc.2000.4226.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"5040_CR65","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12882-018-1094-z","volume":"19","author":"D Zou","year":"2018","unstructured":"Zou D, Wu W, He Y, Ma S, Gao J. The role of Klotho in chronic kidney disease. BMC Nephrol. 2018;19(1):285. https:\/\/doi.org\/10.1186\/s12882-018-1094-z.","journal-title":"BMC Nephrol"},{"issue":"10","key":"5040_CR66","doi-asserted-by":"publisher","first-page":"8655","DOI":"10.1074\/jbc.M110.174037","volume":"286","author":"S Doi","year":"2011","unstructured":"Doi S, Zou Y, Togao O, Pastor JV, John GB, Wang L, et al. Klotho inhibits transforming growth Factor-\u03b21 (TGF-\u03b21) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem. 2011;286(10):8655\u201365. https:\/\/doi.org\/10.1074\/jbc.M110.174037.","journal-title":"J Biol Chem"},{"issue":"1","key":"5040_CR67","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1681\/ASN.2009121311","volume":"22","author":"MC Hu","year":"2011","unstructured":"Hu MC, Shi M, Zhang J, Qui\u00f1ones H, Griffith C, Kuro-o M, et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2011;22(1):124\u201336. https:\/\/doi.org\/10.1681\/ASN.2009121311.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"5040_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23095012","volume":"23","author":"SH Kim","year":"2022","unstructured":"Kim SH, Jin JA, So HJ, Lee SH, Kang TW, Lee JU, et al. Urine-derived stem cell-secreted Klotho plays a crucial role in the HK-2 fibrosis model by inhibiting the TGF-\u03b2 signaling pathway. Int J Mol Sci. 2022;23(9):5012. https:\/\/doi.org\/10.3390\/ijms23095012.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5040_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03595-y","volume":"14","author":"SH Kim","year":"2023","unstructured":"Kim SH, Lee SH, Jin JA, So HJ, Lee JU, Ji MJ, et al. In vivo safety and biodistribution profile of Klotho-enhanced human urine-derived stem cells for clinical application. Stem Cell Res Ther. 2023;14(1):355. https:\/\/doi.org\/10.1186\/s13287-023-03595-y.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5040_CR70","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13287-018-0876-3","volume":"9","author":"YHK Yang","year":"2018","unstructured":"Yang YHK, Ogando CR, Wang See C, Chang TY, Barabino GA. Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro. Stem Cell Res Ther. 2018;9(1):131. https:\/\/doi.org\/10.1186\/s13287-018-0876-3.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5040_CR71","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13759","volume":"22","author":"K Miclau","year":"2022","unstructured":"Miclau K, Hambright WS, Huard J, Stoddart MJ, Bahney CS. Cellular expansion of MSCs: shifting the regenerative potential. Aging Cell. 2022;22(1):e13759. https:\/\/doi.org\/10.1111\/acel.13759.","journal-title":"Aging Cell"},{"issue":"9","key":"5040_CR72","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1016\/j.celrep.2018.02.013","volume":"22","author":"R Chinnadurai","year":"2018","unstructured":"Chinnadurai R, Rajan D, Qayed M, Arafat D, Garcia M, Liu Y, et al. Potency analysis of mesenchymal stromal cells using a combinatorial assay matrix approach. Cell Rep. 2018;22(9):2504\u201317. https:\/\/doi.org\/10.1016\/j.celrep.2018.02.013.","journal-title":"Cell Rep"},{"issue":"10","key":"5040_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/jex2.63","volume":"1","author":"L Paolini","year":"2022","unstructured":"Paolini L, Mongui\u00f3-Tortajada M, Costa M, Antenucci F, Barilani M, Clos\u2010Sansalvador M, et al. Large\u2010scale production of extracellular vesicles: report on the \u201cmassivEVs\u201d ISEV workshop. J Extracell Biol. 2022;1(10):e63. https:\/\/doi.org\/10.1002\/jex2.63.","journal-title":"J Extracell Biol"},{"issue":"12","key":"5040_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70095","volume":"14","author":"P Burdeyron","year":"2024","unstructured":"Burdeyron P, Giraud S, Lepoittevin M, Jordan N, Brishoual S, Jacquard M, et al. Dynamic conditioning of porcine kidney grafts with extracellular vesicles derived from urine progenitor cells: a proof-of\u2010concept study. Clin Transl Med. 2024;14(12):e70095. https:\/\/doi.org\/10.1002\/ctm2.70095.","journal-title":"Clin Transl Med"},{"key":"5040_CR75","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2021.0137","author":"N Zhang","year":"2021","unstructured":"Zhang N, Zhao L, Liu D, Hu C, Wang Y, He T, et al. Characterization of urine-derived stem cells from patients with end-stage liver diseases and application to induced acute and chronic liver injury of nude mice model. Stem Cells Dev. 2021. https:\/\/doi.org\/10.1089\/scd.2021.0137.","journal-title":"Stem Cells Dev"},{"issue":"5","key":"5040_CR76","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s10616-017-0084-5","volume":"69","author":"P Gao","year":"2017","unstructured":"Gao P, Han P, Jiang D, Yang S, Cui Q, Li Z. Effects of the donor age on proliferation, senescence and osteogenic capacity of human urine-derived stem cells. Cytotechnology. 2017;69(5):751\u201363. https:\/\/doi.org\/10.1007\/s10616-017-0084-5.","journal-title":"Cytotechnology"},{"issue":"1","key":"5040_CR77","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1172\/JCI40435","volume":"120","author":"I Hyun","year":"2010","unstructured":"Hyun I. The bioethics of stem cell research and therapy. J Clin Invest. 2010;120(1):71\u20135. https:\/\/doi.org\/10.1172\/JCI40435.","journal-title":"J Clin Invest"},{"key":"5040_CR78","unstructured":"European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP). Guideline on human cell-based medicinal products [EMA Guideline]. London: European Medicines Agency; 2008. Report No.: EMEA\/CHMP\/410869\/2006. Available from: https:\/\/www.ema.europa.eu\/en\/human-cell-based-medicinal-products-scientific-guideline. Accessed 2 Sept 2025."},{"issue":"1","key":"5040_CR79","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13287-024-03863-5","volume":"15","author":"B Zhou","year":"2024","unstructured":"Zhou B, Chen Q, Zhang Q, Tian W, Chen T, Liu Z. Therapeutic potential of adipose-derived stem cell extracellular vesicles: from inflammation regulation to tissue repair. Stem Cell Res Ther. 2024;15(1):249. https:\/\/doi.org\/10.1186\/s13287-024-03863-5.","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"5040_CR80","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13904","volume":"17","author":"C Wang","year":"2024","unstructured":"Wang C, Tsai T, Lee C. Regulation of exosomes as biologic medicines: regulatory challenges faced in exosome development and manufacturing processes. Clin Transl Sci. 2024;17(8):e13904. https:\/\/doi.org\/10.1111\/cts.13904.","journal-title":"Clin Transl Sci"},{"issue":"12","key":"5040_CR81","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/apm.13352","volume":"131","author":"J Kresse","year":"2023","unstructured":"Kresse J, Gregersen E, Atay JCL, Eijken M, N\u00f8rregaard R. Does the route matter? A preclinical review of mesenchymal stromal cell delivery to the kidney. APMIS. 2023;131(12):687\u201397. https:\/\/doi.org\/10.1111\/apm.13352.","journal-title":"APMIS"},{"key":"5040_CR82","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.coche.2016.11.003","volume":"15","author":"AA Foster","year":"2017","unstructured":"Foster AA, Marquardt LM, Heilshorn SC. The diverse roles of hydrogel mechanics in injectable stem cell transplantation. Curr Opin Chem Eng. 2017;15:15\u201323. https:\/\/doi.org\/10.1016\/j.coche.2016.11.003.","journal-title":"Curr Opin Chem Eng"},{"issue":"17","key":"5040_CR83","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1042\/CS20180434","volume":"132","author":"ML McFetridge","year":"2018","unstructured":"McFetridge ML, Del Borgo MP, Aguilar MI, Ricardo SD. The use of hydrogels for cell-based treatment of chronic kidney disease. Clin Sci. 2018;132(17):1977\u201394. https:\/\/doi.org\/10.1042\/CS20180434.","journal-title":"Clin Sci"},{"issue":"1","key":"5040_CR84","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.kint.2020.07.043","volume":"99","author":"HJ Park","year":"2021","unstructured":"Park HJ, Kong MJ, Jang HJ, Cho JI, Park EJ, Lee IK, et al. A nonbiodegradable scaffold-free cell sheet of genome-engineered mesenchymal stem cells inhibits development of acute kidney injury. Kidney Int. 2021;99(1):117\u201333. https:\/\/doi.org\/10.1016\/j.kint.2020.07.043.","journal-title":"Kidney Int"},{"key":"5040_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010459","author":"AA Zidan","year":"2021","unstructured":"Zidan AA, Al-Hawwas M, Perkins GB, Mourad GM, Stapledon CJM, Bobrovskaya L, et al. Characterization of urine stem cell-derived extracellular vesicles reveals B cell stimulating cargo. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22010459.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5040_CR86","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.7150\/thno.22958","volume":"8","author":"CY Chen","year":"2018","unstructured":"Chen CY, Rao SS, Ren L, Hu XK, Tan YJ, Hu Y, et al. Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis. Theranostics. 2018;8(6):1607\u201323. https:\/\/doi.org\/10.7150\/thno.22958. PubMed PMID: 29556344; PubMed Central PMCID: PMC5858170.","journal-title":"Theranostics"},{"issue":"1","key":"5040_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01735-1","volume":"9","author":"MA Kumar","year":"2024","unstructured":"Kumar MA, Baba SK, Sadida HQ, Marzooqi SA, Jerobin J, Altemani FH, et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct Target Ther. 2024;9(1):27. https:\/\/doi.org\/10.1038\/s41392-024-01735-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5040_CR88","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1779346","volume":"2022","author":"S Chen","year":"2022","unstructured":"Chen S, Sun F, Qian H, Xu W, Jiang J. Preconditioning and engineering strategies for improving the efficacy of mesenchymal stem cell-derived exosomes in cell-free therapy. Stem Cells Int. 2022;2022(1):1779346. https:\/\/doi.org\/10.1155\/2022\/1779346.","journal-title":"Stem Cells Int"},{"issue":"5","key":"5040_CR89","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1089\/cell.2021.0051","volume":"23","author":"Y Jin","year":"2021","unstructured":"Jin Y, Zhang M, Li M, Zhang H, Zhang F, Zhang H, et al. Generation of urine-derived induced pluripotent stem cell line from patients with acute kidney injury. Cell Reprogram. 2021;23(5):290\u2013303. https:\/\/doi.org\/10.1089\/cell.2021.0051.","journal-title":"Cell Reprogram"},{"key":"5040_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2020.102085","volume":"49","author":"X Guo","year":"2020","unstructured":"Guo X, Ji W, Niu C, Ding Y, Chen Z, Chen C, et al. Generation of an urine-derived induced pluripotent stem cell line from a 5-year old X-linked Alport syndrome (X-LAS) patient. Stem Cell Res. 2020;49:102085. https:\/\/doi.org\/10.1016\/j.scr.2020.102085.","journal-title":"Stem Cell Res"},{"key":"5040_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2023.103071","volume":"69","author":"L Batool","year":"2023","unstructured":"Batool L, Raab C, Beez CM, Kurtz A, Gollasch M, Rossbach B. Generation of human induced pluripotent stem cell line (BCRTi007-A) from urinary cells of a patient with autosomal dominant polycystic kidney disease. Stem Cell Res. 2023;69:103071. https:\/\/doi.org\/10.1016\/j.scr.2023.103071.","journal-title":"Stem Cell Res"},{"issue":"4","key":"5040_CR92","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41390-019-0618-y","volume":"87","author":"J Mulder","year":"2020","unstructured":"Mulder J, Sharmin S, Chow T, Rodrigues DC, Hildebrandt MR, D\u2019Cruz R, et al. Generation of infant- and pediatric-derived urinary induced pluripotent stem cells competent to form kidney organoids. Pediatr Res. 2020;87(4):647\u201355. https:\/\/doi.org\/10.1038\/s41390-019-0618-y.","journal-title":"Pediatr Res"},{"key":"5040_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9030827","author":"K Kim","year":"2020","unstructured":"Kim K, Gil M, Dayem AA, Choi S, Kang GH, Yang GM, et al. Improved isolation and culture of urine-derived stem cells (USCs) and enhanced production of immune cells from the USC-derived induced pluripotent stem cells. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9030827.","journal-title":"J Clin Med"},{"issue":"7313","key":"5040_CR94","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature09342","volume":"467","author":"K Kim","year":"2010","unstructured":"Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, et al. Epigenetic memory in induced pluripotent stem cells. Nature. 2010;467(7313):285\u201390. https:\/\/doi.org\/10.1038\/nature09342.","journal-title":"Nature"},{"issue":"4","key":"5040_CR95","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3390\/cells11040635","volume":"11","author":"L Nguyen","year":"2022","unstructured":"Nguyen L, Wruck W, Erichsen L, Graffmann N, Adjaye J. The nephrotoxin Puromycin Aminonucleoside induces injury in kidney organoids differentiated from induced pluripotent stem cells. Cells. 2022;11(4):635. https:\/\/doi.org\/10.3390\/cells11040635. (PubMed PMID: 35203286; PubMed Central PMCID: PMC8870209).","journal-title":"Cells"},{"issue":"2","key":"5040_CR96","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.scr.2013.12.004","volume":"12","author":"X Guan","year":"2014","unstructured":"Guan X, Mack DL, Moreno CM, Strande JL, Mathieu J, Shi Y, et al. Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery. Stem Cell Res. 2014;12(2):467\u201380. https:\/\/doi.org\/10.1016\/j.scr.2013.12.004.","journal-title":"Stem Cell Res"},{"issue":"8","key":"5040_CR97","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1681\/ASN.2014010057","volume":"26","author":"E Lazzeri","year":"2015","unstructured":"Lazzeri E, Ronconi E, Angelotti ML, Peired A, Mazzinghi B, Becherucci F, et al. Human urine-derived renal progenitors for personalized modeling of genetic kidney disorders. J Am Soc Nephrol. 2015;26(8):1961\u201374. https:\/\/doi.org\/10.1681\/ASN.2014010057.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"5040_CR98","doi-asserted-by":"publisher","first-page":"6701","DOI":"10.1021\/acsbiomaterials.0c01468","volume":"6","author":"H Guo","year":"2020","unstructured":"Guo H, Deng N, Dou L, Ding H, Criswell T, Atala A, et al. 3-D human renal tubular organoids generated from urine-derived stem cells for nephrotoxicity screening. ACS Biomater Sci Eng. 2020;6(12):6701\u20139. https:\/\/doi.org\/10.1021\/acsbiomaterials.0c01468.","journal-title":"ACS Biomater Sci Eng"},{"issue":"1","key":"5040_CR99","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s13287-020-01822-4","volume":"11","author":"G Sun","year":"2020","unstructured":"Sun G, Ding B, Wan M, Chen L, Jackson J, Atala A. Formation and optimization of three-dimensional organoids generated from urine-derived stem cells for renal function in vitro. Stem Cell Res Ther. 2020;11(1):309. https:\/\/doi.org\/10.1186\/s13287-020-01822-4.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5040_CR100","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41592-018-0253-2","volume":"16","author":"B Phipson","year":"2019","unstructured":"Phipson B, Er PX, Combes AN, Forbes TA, Howden SE, Zappia L, et al. Evaluation of variability in human kidney organoids. Nat Methods. 2019;16(1):79\u201387. https:\/\/doi.org\/10.1038\/s41592-018-0253-2.","journal-title":"Nat Methods"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05040-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05040-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05040-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:16:52Z","timestamp":1781133412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05040-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5040"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05040-2","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}